EUVIMEDEUVIMED entdecken
Crossref

Curcumol reduces lower limb arteriosclerosis in rats by inhibiting human arterial smooth muscle cell activity

Shengzhuang Yang, Gaosheng Huang, Xiangsen Liang, Yu Sun, Lei Xian

Clinical and Experimental Pharmacology and Physiology · 2024

DOI: 10.1111/1440-1681.13867 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, 2024. Verfasst von Shengzhuang Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Thoracic Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: Sesquiterpenes, Arteriosclerosis, Cell Proliferation, Myocytes, Smooth Muscle. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular diseases, particularly those involving arterial stenosis and smooth muscle cell proliferation, pose significant health risks. This study aimed to investigate the therapeutic potential of curcumol in inhibiting platelet‐derived growth factor‐BB (PDGF‐BB)‐induced human aortic smooth muscle cell (HASMC) proliferation, migration and autophagy. Using cell viability assays, 5‐ethynyl‐2′‐deoxyuridine (EdU) incorporation assays and Western Blot analyses, we observed that curcumol effectively attenuated PDGF‐BB‐induced HASMC proliferation and migration in a concentration‐dependent manner. Furthermore, curcumol mitigated PDGF‐BB‐induced autophagy, as evidenced by the downregulation of LC3‐II/LC3‐I ratio and upregulation of P62. In vivo experiments using an arteriosclerosis obliterans model demonstrated that curcumol treatment significantly ameliorated arterial morphology and reduced stenosis. Additionally, curcumol inhibited the activity of the KLF5/COX2 axis, a key pathway in vascular diseases. These findings suggest that curcumol has the potential to serve as a multi‐target therapeutic agent for vascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SesquiterpenesArteriosclerosisCell ProliferationMyocytes, Smooth MuscleMuscle, Smooth, VascularAnimalsHumansRatsMaleCell MovementLower ExtremityAutophagyRats, Sprague-DawleyBecaplermin

Stichwörter der Autor:innen

CurcumolHASMC proliferationPDGF‐BBarterial stenosisautophagy

Substanzen

curcumolSesquiterpenesBecaplermin

Autor:innen und Institutionen

  • Department of Cardiovascular Thoracic Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.

Zitieren

APA

Yang, S., Huang, G., Liang, X., Sun, Y., & Xian, L. (2024). Curcumol reduces lower limb arteriosclerosis in rats by inhibiting human arterial smooth muscle cell activity. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/1440-1681.13867

Vancouver

Yang S, Huang G, Liang X, Sun Y, Xian L. Curcumol reduces lower limb arteriosclerosis in rats by inhibiting human arterial smooth muscle cell activity. Clinical and Experimental Pharmacology and Physiology. 2024. doi:10.1111/1440-1681.13867

BibTeX
@article{Yang2024,
  author = {Yang, Shengzhuang and Huang, Gaosheng and Liang, Xiangsen and Sun, Yu and Xian, Lei},
  title = {Curcumol reduces lower limb arteriosclerosis in rats by inhibiting human arterial smooth muscle cell activity},
  journal = {Clinical and Experimental Pharmacology and Physiology},
  year = {2024},
  doi = {10.1111/1440-1681.13867}
}
Kostenlos starten →